Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
CDD and Lilly say their agreement paves the way for the planned integration of L...
CEO Tomoyuki Hasegawa discusses the vast potential of stem cells and the company...
Regeneron will marry its antibody capabilities with Parabilis’ stabilized helica...
A new study shows that the Golgi proteins GOLPH3 and MYO18A control delivery of ...
The immortalized cell line developed by Kraig Biocraft Labs’ scientists has also...
Researchers discovered that gut bacteria use a flexible survival strategy, epige...
The baby chicks were shifting and starting to pip—or trying to hatch. But not fr...
AI scientists that use reasoning systems to connect hypothesis generation, exper...
The baby chicks were shifting and starting to pip—or trying to hatch. But not fr...
In this GEN webinar, Justin Byers and Daniel Lin-Arlow, PhD, examine how enzymat...
Researchers identified the synaptic protein EPAC2 as a potential therapeutic tar...
A University of Bath, University of Oxford, and Johns Hopkins team is using orga...
A new study compares two prevailing models, cuprizone (CPZ) and lysophosphatidyl...
Advances in individualized therapies targeting specific genetic conditions offer...
Investors and analysts concluded Regenxbio's positive data was not encouraging e...
The American Society for Gene and Cell Therapy (ASGCT) CEO David Barrett, JD, no...
